Right now, the “return of results” issue is a critical point of debate for investigators conducting clinical research studies involving genome scale sequencing. ... Already there are examples in the research community in which patients have been
The age to start and discontinue mammography, screening intervals, the role of imaging methods other than mammography, and the role of clinical breast examination have been points of disagreement among guideline ... Winners of the national abstract
and clinical research targeting infectious pathogens. ... Last time I checked, sharps injuries were on the rise, so investment in prevention research remains critical. .
Samuel C. Durso, MD, MBA, FACP, Theodore Woodward Award for Education and Research. ... Thomas L. Pallone, MD, Mary Betty Stevens Award for Clinical Research.
Kelso, who is a clinical professor of pediatrics and internal medicine at the University of California, San Diego, and faculty at the Scripps Clinic. ... Phillips, who is the John A. Oates Chair in Clinical Research and professor of medicine and
Jelley, who is professor and vice chair for research at the department of internal medicine and assistant dean for clinical research at the University of Oklahoma School of Community Medicine in ... Dr. Himmelstein, distinguished professor of public
Harrington, MD, professor of medicine, division of cardiology, and director, Duke Clinical Research Institute, Durham, N.C. ... then explain them to their patients (see sidebar “Talking to patients about clinical trials”).
https://acpinternist.org/archives/2014/09/editors.htm. This issue covers topics including clinical research on gluten sensitivity, proper preoperative assessments, and how to effectively prescribe methadone. ... In our cover story, Charlotte Huff
The program also provides prevention education and antiretroviral therapy through the President's Emergency Plan for AIDS Relief (PEPFAR) in four African nations where the program conducts clinical research studies. ... We are directly partnering with
Programs in both basic genomic research and applied clinical research directed at promising genomic discoveries need to be grown. ... Very likely some of the needed growth will be transparent and to some extent cost-neutral; for example, in clinical